Nicholas Geraghty
Nicholas Geraghty
Verified email at uowmail.edu.au
TitleCited byYear
Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells
A Pupovac, NJ Geraghty, D Watson, R Sluyter
Immunology and cell biology 93 (1), 77-85, 2015
172015
The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon‐γ in a humanized mouse model of graft‐versus‐host disease
NJ Geraghty, L Belfiore, D Ly, SR Adhikary, SJ Fuller, W Varikatt, ...
Clinical & Experimental Immunology 190 (1), 79-95, 2017
122017
P2X7 receptor in skin biology and diseases
N Geraghty, D Watson, S Adhikary, R Sluyter
112016
The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice
NJ Geraghty, KJ Mansfield, SJ Fuller, D Watson, R Sluyter
Purinergic signalling 13 (4), 405-415, 2017
72017
Increased splenic human CD4+: CD8+ T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in …
NJ Geraghty, L Belfiore, SR Adhikary, SI Alexander, R Sluyter, D Watson
Transplant immunology 54, 38-46, 2019
32019
Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease
NJ Geraghty, D Watson, R Sluyter
Cellular immunology 336, 12-19, 2019
32019
The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease
NJ Geraghty, SR Adhikary, D Watson, R Sluyter
International immunopharmacology 72, 479-486, 2019
2019
Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft‐versus‐host disease
NJ Geraghty, D Watson, R Sluyter
Immunology and cell biology 97 (6), 597-610, 2019
2019
Altered donor P2X7 activity in human leukocytes correlates with P2RX7 genotype but does not affect the development of graft-versus-host disease in humanised mice
SR Adhikary, NJ Geraghty, P Cuthbertson, R Sluyter, D Watson
Purinergic signalling 15 (2), 177-192, 2019
2019
The Role of Purinergic Signalling in Inflammatory Disorders
NJ Geraghty
2019
Pro-inflammatory role of the ATP/P2X7 signalling axis in graft-versus-host disease in humanised mice
NJ Geraghty, SR Adhikary, P Cuthbertson, D Ly, T Guy, L Belfiore, ...
PURINERGIC SIGNALLING 14, S57-S58, 2018
2018
In Vivo Depletion of Dividing Donor Cells Using Post-Transplant Cyclophosphamide can Reduce the Development of Graft-Versus-Host Disease in a Humanised Mouse Model
S Adhikary, N Geraghty, S Alexander, R Sluyter, D Watson
Transplantation 102, S235, 2018
2018
The role of the P2X7 receptor in an imiquimod-induced psoriasis-like mouse model
N Geraghty, D Watson, S Fuller, V Sluyter, R Sluyter
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 393-393, 2016
2016
P2X7 polymorphisms and the role of P2X7 in graft-versus-host disease
S Adhikary, N Geraghty, L Belfiore, S Alexander, R Sluyter, D Watson
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 725-725, 2016
2016
P2X7 BLOCKADE REDUCES INTERFERON GAMMA IN A HUMANISED MOUSE MODEL OF GRAFT-VERSUS-HOST DISEASE.
N Geraghty, L Belfiore, P Mullany, SR Adhikary, S Alexander, R Sluyter, ...
TRANSPLANTATION 99 (11), S5-S5, 2015
2015
Name of Journal: World Journal of Dermatology ESPS Manuscript NO: 22633 Manuscript Type: Review P2X7 receptor in skin biology and diseases
NJ Geraghty, D Watson, SR Adhikary, R Sluyter
The system can't perform the operation now. Try again later.
Articles 1–16